Dehydroxymethylepoxyquinomicin, also known as (-)-DHMEQ, is a potent, selective, and irreversible NF-κB inhibitor that covalently binds to a cysteine residue. This chemical compound is known to inhibit the nuclear translocation of NF-κB, which plays a crucial role in various cellular processes. It exhibits significant anti-inflammatory and anticancer activities.
- Potent and selective NF-κB inhibitor
- Irreversibly binds to a cysteine residue
- Inhibits nuclear translocation of NF-κB
- Exhibits anti-inflammatory activity
- Demonstrates anticancer activity